IBDEI31O ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48616,1,4,0)
;;=4^G90.01
;;^UTILITY(U,$J,358.3,48616,2)
;;=^5004160
;;^UTILITY(U,$J,358.3,48617,0)
;;=G37.9^^185^2424^15
;;^UTILITY(U,$J,358.3,48617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48617,1,3,0)
;;=3^Central Nervous System Demyelinating Disease,Unspec
;;^UTILITY(U,$J,358.3,48617,1,4,0)
;;=4^G37.9
;;^UTILITY(U,$J,358.3,48617,2)
;;=^5003828
;;^UTILITY(U,$J,358.3,48618,0)
;;=G96.9^^185^2424^16
;;^UTILITY(U,$J,358.3,48618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48618,1,3,0)
;;=3^Central Nervous System Disorder,Unspec
;;^UTILITY(U,$J,358.3,48618,1,4,0)
;;=4^G96.9
;;^UTILITY(U,$J,358.3,48618,2)
;;=^5004200
;;^UTILITY(U,$J,358.3,48619,0)
;;=I63.50^^185^2424^17
;;^UTILITY(U,$J,358.3,48619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48619,1,3,0)
;;=3^Cereb infrc due to unsp occls or stenos of unsp cereb artery
;;^UTILITY(U,$J,358.3,48619,1,4,0)
;;=4^I63.50
;;^UTILITY(U,$J,358.3,48619,2)
;;=^5007343
;;^UTILITY(U,$J,358.3,48620,0)
;;=I67.89^^185^2424^38
;;^UTILITY(U,$J,358.3,48620,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48620,1,3,0)
;;=3^Cerebrovascular Disease,Other
;;^UTILITY(U,$J,358.3,48620,1,4,0)
;;=4^I67.89
;;^UTILITY(U,$J,358.3,48620,2)
;;=^5007388
;;^UTILITY(U,$J,358.3,48621,0)
;;=I69.920^^185^2424^18
;;^UTILITY(U,$J,358.3,48621,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48621,1,3,0)
;;=3^Cerebrovascular Disease,Aphasia,Unspec
;;^UTILITY(U,$J,358.3,48621,1,4,0)
;;=4^I69.920
;;^UTILITY(U,$J,358.3,48621,2)
;;=^5007553
;;^UTILITY(U,$J,358.3,48622,0)
;;=I69.990^^185^2424^19
;;^UTILITY(U,$J,358.3,48622,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48622,1,3,0)
;;=3^Cerebrovascular Disease,Apraxia,Unspec
;;^UTILITY(U,$J,358.3,48622,1,4,0)
;;=4^I69.990
;;^UTILITY(U,$J,358.3,48622,2)
;;=^5007568
;;^UTILITY(U,$J,358.3,48623,0)
;;=I69.993^^185^2424^20
;;^UTILITY(U,$J,358.3,48623,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48623,1,3,0)
;;=3^Cerebrovascular Disease,Ataxia,Unspec
;;^UTILITY(U,$J,358.3,48623,1,4,0)
;;=4^I69.993
;;^UTILITY(U,$J,358.3,48623,2)
;;=^5007571
;;^UTILITY(U,$J,358.3,48624,0)
;;=I69.922^^185^2424^21
;;^UTILITY(U,$J,358.3,48624,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48624,1,3,0)
;;=3^Cerebrovascular Disease,Dysarthria,Unspec
;;^UTILITY(U,$J,358.3,48624,1,4,0)
;;=4^I69.922
;;^UTILITY(U,$J,358.3,48624,2)
;;=^5007555
;;^UTILITY(U,$J,358.3,48625,0)
;;=I69.991^^185^2424^22
;;^UTILITY(U,$J,358.3,48625,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48625,1,3,0)
;;=3^Cerebrovascular Disease,Dysphagia
;;^UTILITY(U,$J,358.3,48625,1,4,0)
;;=4^I69.991
;;^UTILITY(U,$J,358.3,48625,2)
;;=^5007569
;;^UTILITY(U,$J,358.3,48626,0)
;;=I69.921^^185^2424^23
;;^UTILITY(U,$J,358.3,48626,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48626,1,3,0)
;;=3^Cerebrovascular Disease,Dysphasia
;;^UTILITY(U,$J,358.3,48626,1,4,0)
;;=4^I69.921
;;^UTILITY(U,$J,358.3,48626,2)
;;=^5007554
;;^UTILITY(U,$J,358.3,48627,0)
;;=I69.992^^185^2424^24
;;^UTILITY(U,$J,358.3,48627,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48627,1,3,0)
;;=3^Cerebrovascular Disease,Facial Weakness
;;^UTILITY(U,$J,358.3,48627,1,4,0)
;;=4^I69.992
;;^UTILITY(U,$J,358.3,48627,2)
;;=^5007570
;;^UTILITY(U,$J,358.3,48628,0)
;;=I69.923^^185^2424^25
;;^UTILITY(U,$J,358.3,48628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48628,1,3,0)
;;=3^Cerebrovascular Disease,Fluency Disorder
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI31O 3804 printed Apr 09, 2024@21:41:30 Page 2
IBDEI31O ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48616,1,4,0)
+2 ;;=4^G90.01
+3 ;;^UTILITY(U,$J,358.3,48616,2)
+4 ;;=^5004160
+5 ;;^UTILITY(U,$J,358.3,48617,0)
+6 ;;=G37.9^^185^2424^15
+7 ;;^UTILITY(U,$J,358.3,48617,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,48617,1,3,0)
+10 ;;=3^Central Nervous System Demyelinating Disease,Unspec
+11 ;;^UTILITY(U,$J,358.3,48617,1,4,0)
+12 ;;=4^G37.9
+13 ;;^UTILITY(U,$J,358.3,48617,2)
+14 ;;=^5003828
+15 ;;^UTILITY(U,$J,358.3,48618,0)
+16 ;;=G96.9^^185^2424^16
+17 ;;^UTILITY(U,$J,358.3,48618,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,48618,1,3,0)
+20 ;;=3^Central Nervous System Disorder,Unspec
+21 ;;^UTILITY(U,$J,358.3,48618,1,4,0)
+22 ;;=4^G96.9
+23 ;;^UTILITY(U,$J,358.3,48618,2)
+24 ;;=^5004200
+25 ;;^UTILITY(U,$J,358.3,48619,0)
+26 ;;=I63.50^^185^2424^17
+27 ;;^UTILITY(U,$J,358.3,48619,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,48619,1,3,0)
+30 ;;=3^Cereb infrc due to unsp occls or stenos of unsp cereb artery
+31 ;;^UTILITY(U,$J,358.3,48619,1,4,0)
+32 ;;=4^I63.50
+33 ;;^UTILITY(U,$J,358.3,48619,2)
+34 ;;=^5007343
+35 ;;^UTILITY(U,$J,358.3,48620,0)
+36 ;;=I67.89^^185^2424^38
+37 ;;^UTILITY(U,$J,358.3,48620,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,48620,1,3,0)
+40 ;;=3^Cerebrovascular Disease,Other
+41 ;;^UTILITY(U,$J,358.3,48620,1,4,0)
+42 ;;=4^I67.89
+43 ;;^UTILITY(U,$J,358.3,48620,2)
+44 ;;=^5007388
+45 ;;^UTILITY(U,$J,358.3,48621,0)
+46 ;;=I69.920^^185^2424^18
+47 ;;^UTILITY(U,$J,358.3,48621,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,48621,1,3,0)
+50 ;;=3^Cerebrovascular Disease,Aphasia,Unspec
+51 ;;^UTILITY(U,$J,358.3,48621,1,4,0)
+52 ;;=4^I69.920
+53 ;;^UTILITY(U,$J,358.3,48621,2)
+54 ;;=^5007553
+55 ;;^UTILITY(U,$J,358.3,48622,0)
+56 ;;=I69.990^^185^2424^19
+57 ;;^UTILITY(U,$J,358.3,48622,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,48622,1,3,0)
+60 ;;=3^Cerebrovascular Disease,Apraxia,Unspec
+61 ;;^UTILITY(U,$J,358.3,48622,1,4,0)
+62 ;;=4^I69.990
+63 ;;^UTILITY(U,$J,358.3,48622,2)
+64 ;;=^5007568
+65 ;;^UTILITY(U,$J,358.3,48623,0)
+66 ;;=I69.993^^185^2424^20
+67 ;;^UTILITY(U,$J,358.3,48623,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,48623,1,3,0)
+70 ;;=3^Cerebrovascular Disease,Ataxia,Unspec
+71 ;;^UTILITY(U,$J,358.3,48623,1,4,0)
+72 ;;=4^I69.993
+73 ;;^UTILITY(U,$J,358.3,48623,2)
+74 ;;=^5007571
+75 ;;^UTILITY(U,$J,358.3,48624,0)
+76 ;;=I69.922^^185^2424^21
+77 ;;^UTILITY(U,$J,358.3,48624,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,48624,1,3,0)
+80 ;;=3^Cerebrovascular Disease,Dysarthria,Unspec
+81 ;;^UTILITY(U,$J,358.3,48624,1,4,0)
+82 ;;=4^I69.922
+83 ;;^UTILITY(U,$J,358.3,48624,2)
+84 ;;=^5007555
+85 ;;^UTILITY(U,$J,358.3,48625,0)
+86 ;;=I69.991^^185^2424^22
+87 ;;^UTILITY(U,$J,358.3,48625,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,48625,1,3,0)
+90 ;;=3^Cerebrovascular Disease,Dysphagia
+91 ;;^UTILITY(U,$J,358.3,48625,1,4,0)
+92 ;;=4^I69.991
+93 ;;^UTILITY(U,$J,358.3,48625,2)
+94 ;;=^5007569
+95 ;;^UTILITY(U,$J,358.3,48626,0)
+96 ;;=I69.921^^185^2424^23
+97 ;;^UTILITY(U,$J,358.3,48626,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,48626,1,3,0)
+100 ;;=3^Cerebrovascular Disease,Dysphasia
+101 ;;^UTILITY(U,$J,358.3,48626,1,4,0)
+102 ;;=4^I69.921
+103 ;;^UTILITY(U,$J,358.3,48626,2)
+104 ;;=^5007554
+105 ;;^UTILITY(U,$J,358.3,48627,0)
+106 ;;=I69.992^^185^2424^24
+107 ;;^UTILITY(U,$J,358.3,48627,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,48627,1,3,0)
+110 ;;=3^Cerebrovascular Disease,Facial Weakness
+111 ;;^UTILITY(U,$J,358.3,48627,1,4,0)
+112 ;;=4^I69.992
+113 ;;^UTILITY(U,$J,358.3,48627,2)
+114 ;;=^5007570
+115 ;;^UTILITY(U,$J,358.3,48628,0)
+116 ;;=I69.923^^185^2424^25
+117 ;;^UTILITY(U,$J,358.3,48628,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,48628,1,3,0)
+120 ;;=3^Cerebrovascular Disease,Fluency Disorder
